Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics (Q35038755)

5 August 2017

1 reference

title

Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics (English)

1 reference

5 August 2017

Muralidhar Beeram

1

1 reference

5 August 2017

Amita Patnaik

series ordinal

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Hematology / Oncology Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

16

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

1089-1100

1 reference

Dose-response is alive and well

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Conventional cancer therapy: promise broken or promise delayed?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Clinical evaluation of biologically targeted drugs: obstacles and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Pharmaceutical research in molecular oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

New molecular targets for cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Development of target-based antineoplastic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Growth Curve of an Experimental Solid Tumor Following Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

The ins and outs of Raf kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

The MAP kinase cascade is essential for diverse signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Raf-1 protein kinase activates the NF-kappa B transcription factor by dissociating the cytoplasmic NF-kappa B-I kappa B complex

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Activation of c-Raf-1 by Ras and Src through different mechanisms: activation in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Protein kinase C alpha activates RAF-1 by direct phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Phosphorylation of Raf by ceramide-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900054-0

7 January 2021

10.1016/S0889-8588(02)00054-0

Identifiers

DOI

1 reference

5 August 2017

1 reference